Mesoblast (MESO) Asset Utilization Ratio (2017 - 2023)

Mesoblast's (MESO) quarterly Asset Utilization Ratio came in at 0.01 in Q1 2023, up 4.5% year-on-year from 0.01 in Q1 2022, and up 1.75% quarter-over-quarter from 0.01 in Q4 2022.

Mesoblast (MESO) Asset Utilization Ratio (2017 - 2023) Analysis & Trends

Mesoblast has disclosed Asset Utilization Ratio across 7 years of filings, most recently posting 0.01 for Q1 2023.

  • Asset Utilization Ratio for Q1 2023 came in at 0.01, up 4.5% year-over-year; the trailing twelve-month figure through Mar 2023 was 0.01 (up 4.5% YoY), and the FY2025 annual result was 0.02, changed N/A from the prior year.
  • Asset Utilization Ratio came in at 0.01 for Q1 2023 at Mesoblast, up from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.05 in Q2 2020 to a low of 0.01 in Q1 2019.
  • The 5-year median for Asset Utilization Ratio is 0.01 (2022), against an average of 0.02.
  • Across the five-year window, Asset Utilization Ratio surged 483.17% in 2020 and plunged 78.4% in 2021, its largest moves.
  • Mesoblast's Asset Utilization Ratio stood at 0.01 in 2019, then jumped by 346.56% to 0.05 in 2020, then tumbled by 73.02% to 0.01 in 2021, then grew by 6.32% to 0.01 in 2022, then climbed by 1.75% to 0.01 in 2023.
  • The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2023), 0.01 (Q4 2022), and 0.01 (Q3 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mesoblast 21.68 Bn 21.55 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.02
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.01
Jun 30, 2021 0.01
Mar 31, 2021 0.04
Dec 31, 2020 0.05
Sep 30, 2020 0.04
Jun 30, 2020 0.05
Mar 31, 2020 0.01
Dec 31, 2019 0.01
Sep 30, 2019 0.01
Jun 30, 2019 0.01
Mar 31, 2019 0.01
Dec 31, 2018 0.01
Sep 30, 2018 0.01
Jun 30, 2018 0.01